| Acne Vulgaris
Absorica vs Targadox
Side-by-side clinical, coverage, and cost comparison for acne vulgaris.Deep comparison between: Absorica Ld vs Targadox with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsTargadox has a higher rate of injection site reactions vs Absorica Ld based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Targadox but not Absorica Ld, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Absorica Ld
Targadox
At A Glance
Oral
Twice daily
Retinoid
Oral
Daily to twice daily
Tetracycline antibiotic
Indications
- Acne Vulgaris
- Rocky Mountain Spotted Fever
- TYPHUS
- Q Fever
- Rickettsialpox
- Respiratory Tract Infections
- Respiratory Tract Infections
- Upper Respiratory Infections
- Urinary tract infection
- Lymphogranuloma Venereum
- Psittacosis
- Trachoma
- Inclusion conjunctivitis
- Urethritis
- Uterine Cervicitis
- Proctitis
- non-gonococcal urethritis (NGU)
- Relapsing Fever
- Chancroid
- Plague
- Tularemia
- Cholera
- Campylobacter infection
- Brucellosis
- Bartonella Infections
- Granuloma Inguinale
- Anthrax disease
- Gonorrhea
- Syphilis
- Yaws
- Listeriosis
- Necrotizing Ulcerative Gingivitis
- Actinomycosis
- Clostridium Infections
- Amebiasis
- Acne Vulgaris
- Malaria
Dosing
Acne Vulgaris ABSORICA: 0.5 to 1 mg/kg/day in two divided doses for 15 to 20 weeks (up to 2 mg/kg/day for severe disease with scarring or trunk involvement); ABSORICA LD: 0.4 to 0.8 mg/kg/day in two divided doses for 15 to 20 weeks (up to 1.6 mg/kg/day for severe disease).
Adults (general infections) 200 mg on day 1 (100 mg every 12 hours), then 100 mg/day maintenance; 100 mg every 12 hours for severe or chronic Urinary tract infection.
Pediatric patients <45 kg (severe infections) 2.2 mg/kg every 12 hours; for less severe disease (>8 years, <45 kg): 4.4 mg/kg divided into two doses on day 1, then 2.2 mg/kg/day as a single or divided dose. Children >=45 kg receive the adult dose.
Gonorrhea 100 mg twice daily for 7 days; alternate single-visit dose: 300 mg followed by 300 mg 1 hour later, may be taken with food or beverage.
Urethritis, Uterine Cervicitis, Proctitis, non-gonococcal urethritis (NGU) 100 mg twice daily for 7 days.
Syphilis (early, penicillin-allergic patients) 100 mg twice daily for 2 weeks.
Syphilis (>1 year duration, penicillin-allergic patients) 100 mg twice daily for 4 weeks.
Malaria (prophylaxis) Adults: 100 mg once daily beginning 1-2 days before travel, continuing during travel, and for 4 weeks after leaving the malarious area. Pediatric patients >8 years: 2 mg/kg once daily up to the adult dose.
Anthrax disease (inhalational, post-exposure) Adults: 100 mg twice daily for 60 days. Children <45 kg: 2.2 mg/kg twice daily for 60 days; children >=45 kg receive the adult dose.
Contraindications
- Pregnancy
- Hypersensitivity to isotretinoin, Vitamin A (given chemical similarity), or any component of the product
- Hypersensitivity to any of the tetracyclines
Adverse Reactions
Most common Cheilitis, hypertriglyceridemia, dry skin, dry lips, fatigue, headache, epistaxis, arthralgia, back pain, musculoskeletal pain
Serious Embryo-fetal toxicity, psychiatric disorders (including suicidal ideation, depression, psychosis), intracranial hypertension, serious skin reactions, pancreatitis, hepatotoxicity, inflammatory bowel disease, musculoskeletal abnormalities, hearing impairment, hypersensitivity reactions
Most common Nausea, vomiting, diarrhea, anorexia, glossitis, dysphagia, enterocolitis, maculopapular and erythematous rashes.
Serious Toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis, anaphylactoid purpura, DRESS, intracranial hypertension, hemolytic anemia, thrombocytopenia, hepatotoxicity, esophagitis, esophageal ulceration, permanent tooth discoloration.
Pharmacology
Isotretinoin is a retinoid that inhibits sebaceous gland function and keratinization; clinical improvement in nodular acne is associated with a reduction in sebum secretion, reflecting reduced sebaceous gland size and inhibition of sebaceous gland differentiation.
Tetracycline-class antibacterial; doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, exhibiting bacteriostatic activity against a broad range of Gram-positive and Gram-negative bacteria.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Absorica Ld
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (0/12) · Qty limit (0/12)
Targadox
- Covered on 5 commercial plans
- PA (5/12) · Step Therapy (9/12) · Qty limit (10/12)
UnitedHealthcare
Absorica Ld
- Covered on 4 commercial plans
- PA (2/8) · Step Therapy (0/8) · Qty limit (0/8)
Targadox
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Absorica Ld
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
Targadox
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (2/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Absorica Ld.
No savings programs available for Targadox.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
Absorica LdView full Absorica Ld profile
TargadoxView full Targadox profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.